tirzepatide shortage news today FDA says this weight loss drug is over, but patients worry about cost and availability Eli Lilly's Weight-Loss Drug Zepbound

The Food and Drug Administration approved semaglutide for obesity treatment in 2021, making it the first FDA-approved weight management medication since 2014

It is administered through a once-weekly subcutaneous injection and is often prescribed alongside diet and exercise modifications

[11] [12] Women of childbearing potential should be aware that tirzepatide may reduce the effectiveness of oral contraceptives, particularly during the first 4 weeks after initiation and after each dose escalation

A.et al (1996)

Croom KF, McCormack PL

Itoh M, Uchimura K, Yamamoto K, Makino M, Imamura S, Kobayashi T, Fujiwara K, Kato T, Hayakawa N, Sawai Y, Nagasaka A, Iwase K, Nomura T, Hagino Y